NewswireToday - /newswire/ -
Baden-Baden, Germany, 2011/11/08 - Dr. Eliaz’s presentations were enthusiastically received by doctors and health professionals from around the world. The significant interest generated by this breakthrough research signals the growing demand for successful, science-based integrative.
Isaac Eliaz, MD, LAc, MS, renowned medical doctor, discusses the principles of integrative medicine and the latest research on the role of Modified Citrus Pectin in the treatment of cancer at Medical Week in Baden-Baden, Germany. Medical Week is Europe’s biggest medical congress for complementary medicine. Dr. Isaac Eliaz says,“The main message I shared with my audience is that integrative medicine and integrative oncology is first about the patient and then about the disease. It’s understanding both and integrating them that allows for profound healing to take place.”
Medical Week brings together thousands of healthcare professionals and exhibitors from around the world to share the latest information and advancements in the treatment and prevention of disease. This year’s focus is “Complementary Medicine First!” Dr. Ralph Moss, distinguished lecturer and scientific advisor of the German Oncology Society says,“This annual event is a reminder of just how powerful the movement for integrative medicine is in Germany. It is always heartening for me to return to a country in which complementary medicine is regarded with such great respect.”
During Dr. Eliaz’s visit, he toured several leading cancer clinics in Germany and Austria with Dr. Moss. The trip provided Dr. Eliaz with a rare opportunity to learn, teach and collaborate with the world’s leading integrative oncologists on ideas for a better future in cancer care. “The future of cancer care is, without a doubt, in the true integrative model,” says Dr. Eliaz. At the conference and at the clinics, Dr. Eliaz shared the energetic and philosophical principles of integrative medicine in oncology and how to apply these principles to cancer prevention and treatment. This includes the latest body of research on Modified Citrus Pectin (MCP) and novel polybotanical formulas in suppressing the growth and proliferation of cancer.
Research on Modified Citrus Pectin and Polybotanicals
During Medical Week, Dr. Eliaz discussed the recent research on the role of Modified Citrus Pectin and polybotanicals in the treatment of cancer. He explained specifically how MCP directly attacks cancer by binding to galectin-3 molecules ("sticky" surface molecules that promote angiogenesis and metastasis) and blocking their ability to promote cancer cell growth and metastasis, among other harmful effects.
Over the last decade, a large body of peer-reviewed research has revealed that many of our most serious health concerns are associated with elevated levels of galectin-3 molecules. "Modified Citrus Pectin - derived from citrus peels - is the only proven natural galectin-3 inhibitor and thus offers a powerful and all-natural way to address elevated galectin-3 for cancer, metastasis, and other chronic life threatening illnesses,” says Dr. Eliaz
Dr. Eliaz’s presentations were enthusiastically received by doctors and health professionals from around the world. The significant interest generated by this breakthrough research signals the growing demand for successful, science-based integrative health solutions worldwide.
About Better Health Publishing
Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.